Does CANDESARTAN Cause Hyperparathyroidism secondary? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Hyperparathyroidism secondary have been filed in association with CANDESARTAN. This represents 0.1% of all adverse event reports for CANDESARTAN.
13
Reports of Hyperparathyroidism secondary with CANDESARTAN
0.1%
of all CANDESARTAN reports
0
Deaths
13
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From CANDESARTAN?
Of the 13 reports, 13 (100.0%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN Cause?
Off label use (1,911)
Fatigue (1,468)
Dyspnoea (1,456)
Pain (1,455)
Drug ineffective (1,428)
Headache (1,371)
Nausea (1,282)
Dizziness (1,237)
Vomiting (1,202)
Diarrhoea (1,145)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which CANDESARTAN Alternatives Have Lower Hyperparathyroidism secondary Risk?
CANDESARTAN vs CANDESARTAN CILEXETIL
CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN vs CANGRELOR
CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN vs CANNABIDIOL